Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Canopy Growth

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Tilray Brands

Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs approved the Secure and Fair Enforcement Regulation Banking Act, now known as the SAFER Banking Act of 2023. The bill to open up the financial system to legal cannabis companies now heads to the full Senate for a vote after earlier versions of it were initially introduced on Capitol Hill a decade ago.

Cannabis stock rise as Senate committee OKs cannabis banking bill

This week could be big for most marijuana stocks as legislation is soon to be voted on. During this week key senate members will vote on whether or not to pass the SAFE Banking Act. If this does become law it will be another big step in the right direction. The cannabis industry as a whole has come a long way. Yet cannabis is still federally illegal and this makes it tough for legal operating marijuana businesses.

3 Top Marijuana Stocks To Buy This Monday?

Cronos Group

SNDL Inc.

Cannabis stocks have navigated an extended period of uncertainty and financial depression thanks to regulatory headwinds. Further, most cannabis companies have witnessed an extended period of cash burn.

Hidden Gems: 3 Cannabis Stocks Flying Under the Radar

As we trade this week in September 2023, the landscape of the cannabis market in the United States is undergoing considerable change. Recent federal government debates regarding rescheduling cannabis have sent shockwaves across the financial markets, particularly among investors interested in the marijuana industry. In general, this trend has increased interest in the top US marijuana stocks to watch this month. With regulatory changes likely on the horizon, now is an excellent moment to research the most recent developments, industry statistics, and smart tactics for investors navigating this changing market.

Top US Marijuana Stocks to Watch in September 2023

Is it 2018 all over again? For investors asking: “Why are cannabis stocks up today?

Why Are Cannabis Stocks Up Today?

Aurora Cannabis

Cannabis multi-state operator (MSO) stocks are set to end another week on a high on renewed optimism around marijuana banking reform. The Senate Banking Committee is expected to hold a markup session for the Secure and Fair Enforcement (SAFE) Banking Act in the week starting September 25, according to sources with knowledge of the matter.

Cannabis MSO shares rise with marijuana banking reform poised to win Senate Committee's approval

Yesterday, Canopy Growth announced plans to shut down its BioSteel dietary supplements business to accelerate its push toward profitability. Investment banks applauded the move, with TD Cowen and Bank of America raising their price targets on the stock.

Why Canopy Growth, Aurora Cannabis, Cresco Labs, and Curaleaf Stocks All Popped

The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work with cannabis companies.

Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27

New York's adult-use cannabis market is set to expand with the addition of multi-state operators The New York Cannabis Control Board voted Tuesday to allow non-social equity applicants to apply for licenses to cultivate, manufacture, and sell adult-use cannabis. This would allow major medical marijuana companies in the state such as Acreage Holdings Inc. (CSE:ACRG), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF), Columbia Care Inc (CSE:CCHW, OTCQX:CCHWF, NEO:CCHW) and Cresco Labs Inc. (CSE:CL, OTCQX:CRLBF) to enter a market currently flush with illegal dispensaries and a small number of smaller, legal entrepreneurs.

New York cannabis regulators vote to allow multistate operators into the market

NewLake Capital Partners, Inc.

Alan Brochstein And Julian Lin discuss the importance of navigating timelines and federal legalization headlines in cannabis investing. Preferring REITs and Canadian LPs over US operators due to factors such as debt concerns and valuation.

Unlocking Cannabis: Legalization Timelines, Debt Risk + Unique Value Plays With Alan Brochstein And Julian Lin

Marijuana stocks have seen several days of better trading this past week. There were a few days when the cannabis sector was showing better momentum. This led to a recovery for certain marijuana stocks. Anytime there is a recovery in trading it gives hope towards future investing. No one wants to invest in a dying sector or one with no action. With cannabis being a new industry compared to others it is always a good sign to investors when there is a rise in trading.

Are These Marijuana Stocks Worth Buying Or Selling?

Scotts Miracle-Gro

The U.S. Department of Health and Human Services recently called for cannabis to move from Schedule I (the most restrictive category) to Schedule III. While the transition hasn't taken effect yet, and rescheduling still falls short of decriminalization, a reclassification would have a major impact on U.S. cannabis stocks.

Rescheduling Marijuana 2023: 3 Cannabis Stocks That Could Skyrocket

The New York State Cannabis Control Board on Tuesday voted to open up the application process starting next month for businesses seeking to sell, grow, process and distribute marijuana for adult use. Companies with an existing presence in the state's medical program include Curaleaf Holdings CURLF, -10.69%, RIV Capital Inc. RIV, , a unit of Scotts Miracle-Gro Co. SMG, -0.19% that owns Etain dispensaries; Acreage Holdings Inc. ACRHF, -20.41%, Green Thumb Industries GTBIF, -8.60% and PharmaCann.

New York State opens up cannabis license process

OrganiGram Holdings Inc.

The House of Representatives is set to meet to discuss several pot-related measures this week. The march toward full U.S. legalization continues to gather pace.

Why Marijuana Stocks Triumphed on Monday

IM Cannabis Corp

With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states approve recreational and medical use.

The 3 Best Cannabis Stocks to Buy Now: September 2023

Marijuana stocks could soon see better trading in the weeks to come. For some time now most marijuana stocks have traded with a level of volatility. This can make it both easier and tougher to trade and buy cannabis stocks. For example when there is a recovery in trading that is when most would sell to take some profits. On the other hand, if volatility leads to decline this is where you look for the best marijuana stocks to buy. The basic strategy to understand is to buy low and sell high.

These Marijuana Stocks Could Be Top Gainers In September

Momentum for passage of marijuana reform legislation keeps growing, and senators are confident the SAFE Banking Act will pass. A new study touts the benefits of medical marijuana for pain amelioration.

Why Canopy Growth, Aurora Cannabis, and Curaleaf Stocks All Popped Today

It's been an excellent month for cannabis stocks and it's not hard to see why. All evidence points to the fact that the federal government is considering rescheduling the recreational drug from Schedule I to Schedule III.

Fed Plans to Reschedule Marijuana Will Mostly Benefit These 3 Cannabis Stocks

The global buzz around medical cannabis stocks just got a whole lot louder. The corridors of the U.S. health sector are abuzz with the federal Health and Human Services Department urging the government to re-evaluate its hard stance on marijuana effectively.

3 Medical Cannabis Stocks Poised for Global Growth

Renewed hopes about legal reform have helped cannabis stocks pick up steam. Yet, many marijuana stocks are still trading at deeply discounted prices.

3 Top Cannabis Stocks to Buy for September

Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cannabis companies.

Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging

The rescheduling of marijuana from a Schedule I to Schedule III drug in the United States would be transformative for the cannabis sector, CEOs of leading cannabis companies believe.  Last week, the Department of Health and Human Services (HHS) made a recommendation to the Drug Enforcement Administration (DEA) to re-classify marijuana as a lower-risk drug.

Marijuana rescheduling would be ‘life-changing event' for cannabis companies, CEOs say

New York state's largest medical-cannabis companies, which have been barred from wading into the adult-use market for more than two years, are saying they've waited long enough for licenses from the state.

Medical-cannabis companies blast New York for ‘clear course for failure' in state pot-business rollout

Cannabis stocks have floundered over the past several years. However, the momentum building within the global legalization movement has recently sparked a trend reversal.

3 Top Growth Stocks to Buy in September

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

Constellation Brands

Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human Services recommended that marijuana no longer be classified as a Schedule 1 drug.

Will This New Development Mean A Big Rally In Cannabis Stocks?

News for Curaleaf Holdings, Inc. Stock (CURLF)